![Nick Corcoran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nick Corcoran
Verksamhetschef på
TRANSMEDICS GROUP, INC.
Förmögenhet: 3 M $ per 2026-07-31
Profil
Nick Corcoran currently works at TransMedics Group, Inc., as Senior Vice President-Supply Chain & Operations from 2023.
Mr. Corcoran also formerly worked at Stryker Corp., as Vice President-Division Operations from 2022 to 2023.
Mr. Corcoran received his graduate degree from UCD Michael Smurfit Graduate School of Business and undergraduate degree from South East Technological University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
TRANSMEDICS GROUP, INC. 0,12 % | 2026-07-10 | 41 558 ( 0,12 % ) | 3 M $ | 2026-07-31 |
Aktiva positioner av Nick Corcoran
| Företag | Position | Start |
|---|---|---|
| TRANSMEDICS GROUP, INC. | Verksamhetschef | 2023-02-02 |
Tidigare kända positioner av Nick Corcoran
| Företag | Position | Slut |
|---|---|---|
| STRYKER CORPORATION | Företagsledare/Principal | 2023-01-01 |
Nick Corcorans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
19
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Stryker Corp.
 Stryker Corp. Medical SpecialtiesHealth Technology Manufactures and markets reconstructive, medical and surgical, and neurotechnology and spine products | Health Technology |
UCD Michael Smurfit Graduate School of Business
 UCD Michael Smurfit Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMedics Group, Inc.
 TransMedics Group, Inc. Medical SpecialtiesHealth Technology Manufactures portable electromechanical medical devices for organ transplantation of end-stage organ failure patients | Health Technology |
